Author

Shr-Hau Hung

Scripps Research InstituteORCID 0000-0001-9067-2035Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:non-human primate· 1

Frequent Co-Authors

Eric A. TothiD· 2 shared Erick Giang· 2 shared Jiang ZhuiD· 2 shared Linling HeiD· 2 shared Mansun LawiD· 2 shared Thomas R. FuerstiD· 2 shared Yi-Zong LeeiD· 2 shared Benjamin M. JanusiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Eric A. TothORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCell ReportsPeer-reviewedAug 1, 2026

The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages

Fang Chen, Yen Thi Kim Nguyen, Yi-Zong Lee…·Mansun Law

This study identifies the conserved bridging domain on HCV E1E2 as a target for neutralizing antibodies from diverse lineages, showing additivity with neutralizing face antibodies.

1 citation

non-human primateexperimental assay

𝕏 PostBluesky

MicrobiologyNature CommunicationsPeer-reviewedFeb 11, 2026

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design

Linling He, Yi-Zong Lee, Yi-Nan Zhang…·Jiang Zhu

The paper designs, characterizes, and tests a soluble HCV E1E2 heterodimer and self-assembling nanoparticles for vaccine development.

5 citationstop 1%

experimental assaydrug response / drug discovery

𝕏 PostBluesky